# Xian Yufan Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xian-yufan-biotechnology

- Industry: Biotechnology
- Headquarters: Xi'an, China
- Latest round: Angel (Dec 11, 2017)
- Investors on record: 2

## About

Based in Xi'an, China and established in 2016, Xian Yufan Biotechnology operates as a biotechnology company which focuses on Chimeric Antigen Receptor T-Cell Immunotherapy (Car-T) for cancer treatment.

The company’s main business is the innovation of CAR-T cell therapy and related technologies, offering a comprehensive suite of services including CAR-T cell GMP production, CRISPR/Cas9 gene editing for immune cells, phage antibody library development, and phage display technology.

The company generates revenue by providing its innovative CAR-T cell therapies, antibody screening platforms, and contract research services to biopharmaceutical companies, research institutions, and clinical facilities.

## Funding rounds

- Angel, Dec 11, 2017 — Qm Angel Investment, Xike Angel Fund

## Investors

- Qm Angel Investment — Angel
- Xike Angel Fund (https://capitalatlas.ai/funds/xike-angel-fund) — Angel